OpenAI acquires Orchestra Bio

Company news OpenAI Source language: English

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

Excerpt

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

Short excerpt from the source — open the original for the full text.

Sources

← Back to the daily brief